Integrated Assessment of Endocrine Axes in Chronic Chagas Disease Using a Combined Stimulation Test

Authors

  • Alejandro Marcel Hasslocher-Moreno Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation
  • Carmen Rosemeri Copetti
  • Mauro Tendrich

DOI:

https://doi.org/10.36557/2674-9432.2026v5n5p740-754%20

Keywords:

Chagas disease, hypothalamic-pituitary axis, adrenal reserve, thyroid hormones, endocrine function, combined stimulation test

Abstract

Background: Chronic Chagas disease (CD) is characterized by cardiac and digestive manifestations, but its potential effects on neuroendocrine function remain poorly understood. This study aimed to evaluate the integrity of the hypothalamic-pituitary-target gland axes in patients with chronic CD using a combined hypothalamic stimulation test.

Methods: In this prospective study, 15 patients with chronic CD (five with the indeterminate form and ten with the cardiac form) underwent simultaneous stimulation with corticotropin-releasing hormone (CRH), thyrotropin-releasing hormone (TRH), and luteinizing hormone-releasing hormone (LHRH/GnRH). Dynamic responses of the hypothalamic-pituitary-adrenal (HPA), hypothalamic-pituitary-thyroid (HPT), hypothalamic-pituitary-gonadal (HPG), and prolactin axes were evaluated by serial measurements of ACTH, cortisol, TSH, prolactin, FSH, LH, thyroid hormones, testosterone, estradiol, and reverse T3.

Results: Pituitary function was preserved in all patients, as demonstrated by normal ACTH and TSH responses to CRH and TRH stimulation, respectively. Two patients exhibited reduced cortisol responses despite normal basal cortisol concentrations, suggesting decreased adrenocortical reserve. Reduced free thyroxine (FT4) levels were observed in eight patients, while low T3 syndrome was identified in three patients. Reverse T3 concentrations remained within the normal range in all cases. Prolactin responses were preserved in all but one patient, and basal hyperprolactinemia was observed in two men. Baseline testosterone concentrations and LH responses were normal in male patients, whereas isolated abnormalities in FSH responses and estradiol levels were identified without evidence of clinically significant gonadal dysfunction.

Conclusions: Chronic CD is not associated with generalized dysfunction of the hypothalamic-pituitary endocrine axes. Preserved pituitary responses indicate intact central neuroendocrine regulation, whereas reduced adrenocortical reserve and alterations in thyroid hormone metabolism suggest selective peripheral endocrine adaptations. These findings expand current knowledge of the endocrine manifestations of chronic CD and support further investigation of their clinical significance in larger patient populations.

 

Downloads

Download data is not yet available.

References

1. Saraiva RM, Mediano MFF, Mendes FS, Sperandio da Silva GM, Veloso HH, Sangenis LHC, et al. Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care. WJC. 2021;13(12):654–75. doi:10.4330/wjc.v13.i12.654

2. WHO. Chagas disease (also known as American trypanosomiasis) [Internet]. 2025 [cited August 5, 2025]. Available from: https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis)

3. De Sousa AS, Vermeij D, Ramos AN, Luquetti AO. Chagas disease. The Lancet. 2024;403(10422):203–18. doi:10.1016/S0140-6736(23)01787-7

4. Bea-Serrano C, De Gracia-León AI, Llenas-García J, Vela-Bernal S, Belmonte-Domingo A, Pinto-Pla C, et al. Chagas Disease in a Non-Endemic Setting: Clinical Profile, Treatment Outcomes, and Predictors of Cure in a 15-Year Cohort Study. TropicalMed. 2025;10(6):161. doi:10.3390/tropicalmed10060161

5. Corrêa-de-Santana E, Paez-Pereda M, Theodoropoulou M, Kenji Nihei O, Gruebler Y, Bozza M, et al. Hypothalamus–pituitary–adrenal axis during Trypanosoma cruzi acute infection in mice. Journal of Neuroimmunology. 2006;173(1–2):12–22. doi:10.1016/j.jneuroim.2005.08.015

6. González F, Villar S, D’Attilio L, Leiva R, Marquez J, Lioi S, et al. Dysregulated Network of Immune, Endocrine and Metabolic Markers is Associated to More Severe Human Chronic Chagas Cardiomyopathy. Neuroimmunomodulation. 2018;25(3):119–28. doi:10.1159/000491699

7. González FB, Savino W, Pérez AR. Brain-Thymus connections in Chagas Disease. Neuroimmunomodulation. 2024. doi:10.1159/000538220

8. Faglia G. The Clinical Impact of the Thyrotropin-Releasing Hormone Test. Thyroid. 1998;8(10):903–8. doi:10.1089/thy.1998.8.903

9. Pérez AR, Bottasso OA, Santucci NE. Immune-endocrine crossroads: the impact of nuclear receptors in Tuberculosis and Chagas disease. Front Endocrinol. 2025;16:1538376. doi:10.3389/fendo.2025.1538376

10. González FB, Dinatale B, Savino W, Bottasso OA, Pérez AR. Bridging the Nervous-Endocrine System and Immune Response, in Human Chagas Disease Pathology. Neuroimmunomodulation. 2025;32(1):322–33. doi:10.1159/000548813

11. Fliers E, Boelen A. An update on non-thyroidal illness syndrome. J Endocrinol Invest. 2021;44(8):1597–607. doi:10.1007/s40618-020-01482-4

12. Reboreda-Hernández ÓA, Ortiz-Butron R, Nogeda-Torres B, González-Rodríguez N. Influencia de las hormonas tiroideas en la infección por Trypanosoma cruzi in vitro e in vivo. ACM. 2026;19306. doi:10.24875/ACM.25000045

13. Halperin Y, Shapiro LE, Surks MI. Down-regulation of type II L-thyroxine, 5’-monodeiodinase in cultured GC cells: different pathways of regulation by L-triiodothyronine and 3,3’,5’-triiodo-L-thyronine. Endocrinology. 1994;135(4):1464–9. doi:10.1210/endo.135.4.7925108

14. Del Vecchio Filipin M, Brazão V, Santello FH, Da Costa CMB, Paula Alonso Toldo M, Rossetto De Morais F, et al. Does Prolactin treatment trigger imunoendocrine alterations during experimental T. cruzi infection? Cytokine. 2019;121:154736. doi:10.1016/j.cyto.2019.154736

Published

2026-07-17

How to Cite

HASSLOCHER-MORENO, Alejandro Marcel; COPETTI , Carmen Rosemeri; TENDRICH, Mauro. Integrated Assessment of Endocrine Axes in Chronic Chagas Disease Using a Combined Stimulation Test . Periódicos Brasil. Pesquisa Científica, Macapá, Brasil, v. 5, n. 5, p. 740–754, 2026. DOI: 10.36557/2674-9432.2026v5n5p740-754 . Disponível em: https://periodicosbrasil.emnuvens.com.br/revista/article/view/1321. Acesso em: 17 aug. 2026.